---
title: "LI JIANGUANG — Ownership Dossier"
canonical: https://whiteintel.dev/entity/1e5d6a92-37ef-528e-bbd2-0625744d9fa8
json: https://whiteintel.dev/api/public/dossier/1e5d6a92-37ef-528e-bbd2-0625744d9fa8
identifier: sec:0001664022
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LI JIANGUANG

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001664022`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/1e5d6a92-37ef-528e-bbd2-0625744d9fa8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/1e5d6a92-37ef-528e-bbd2-0625744d9fa8  

## Ownership & control

### Holdings / subsidiaries

- **CASI PHARMACEUTICALS, INC (DE)** (tenpercentowner) — https://whiteintel.dev/entity/1c00e944-4675-594b-beb8-10341985ff8f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LI JIANGUANG**. Human view: https://whiteintel.dev/entity/1e5d6a92-37ef-528e-bbd2-0625744d9fa8 · Structured JSON: https://whiteintel.dev/api/public/dossier/1e5d6a92-37ef-528e-bbd2-0625744d9fa8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._